Stefan Dyckerhoff Sells 8,994 Shares of Astera Labs (NASDAQ:ALAB) Stock

Key Points

• Astera Labs director Stefan Dyckerhoff sold 8,994 shares for approximately $2.8 million at an average price of $311.83 under a pre-arranged Rule 10b5-1 plan, reducing his direct holdings by 69.38% to 3,970 shares.
• Astera Labs shares recently traded at $317.23, down $16.94, while the company reported quarterly EPS of $0.80 and revenue of $392.4 million—beating analyst expectations and marking 104.5% year-over-year revenue growth.
• Analyst sentiment remains positive overall, with a “Moderate Buy” consensus from 23 analysts and an average price target of $325.25; institutional investors own 60.47% of the company.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total value of $2,804,599.02. Following the sale, the director directly owned 3,970 shares in the company, valued at $1,237,965.10. The trade was a 69.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB traded down $16.94 on Monday, hitting $317.23. The company's stock had a trading volume of 3,351,677 shares, compared to its average volume of 5,556,211. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The company has a market capitalization of $55.04 billion, a price-to-earnings ratio of 157.05 and a beta of 3.84. The stock's 50-day moving average is $360.45 and its two-hundred day moving average is $235.65.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company's quarterly revenue was up 104.5% compared to the same quarter last year. During the same period last year, the company earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts expect that Astera Labs, Inc. will post 1.86 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Astera Labs

Large investors have recently modified their holdings of the stock. Reflection Asset Management purchased a new stake in shares of Astera Labs during the fourth quarter valued at $25,000. Smartleaf Asset Management LLC increased its stake in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company's stock worth $32,000 after purchasing an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in Astera Labs in the 4th quarter worth about $33,000. Whipplewood Advisors LLC raised its holdings in Astera Labs by 15,950.0% during the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company's stock worth $35,000 after buying an additional 319 shares during the period. Finally, Assetmark Inc. raised its holdings in Astera Labs by 78.9% during the 4th quarter. Assetmark Inc. now owns 229 shares of the company's stock worth $38,000 after buying an additional 101 shares during the period. 60.47% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have commented on ALAB. Stifel Nicolaus boosted their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a "buy" rating in a research report on Wednesday, June 24th. UBS Group reiterated a "neutral" rating and issued a $425.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. TD Cowen lowered their price objective on shares of Astera Labs from $425.00 to $375.00 and set a "hold" rating on the stock in a research note on Wednesday, August 5th. Bank of America boosted their target price on Astera Labs from $240.00 to $450.00 and gave the stock a "neutral" rating in a report on Tuesday, June 23rd. Finally, Needham & Company LLC upped their target price on Astera Labs from $260.00 to $425.00 and gave the stock a "buy" rating in a research report on Wednesday, August 5th. Thirteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $325.25.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source